Tokyo, Nov. 8 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059684) titled 'An observational study for efficacy and safety of endoscopic retrograde cholangiopancreatography' on Nov. 7.
Study Type:
Observational
Primary Sponsor:
Institute - Fukushima Medical University
Condition:
Condition - Pancreatobiliary diseases
Classification by malignancy - Malignancy
Genomic information - YES
Objective:
Narrative objectives1 - To cralify efficacy and safety of endoscopic retrograde cholangiopancreatography (ERCP) related procedures
Basic objectives2 - Others
Eligibility:
Age-lower limit - Not applicable
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - Cases who underwent ERCP related procedures
Key exclusion criteria - None
Target Size - 9650
Recruitment Status:
Recruitment status - Open public recruiting
Date of protocol fixation - 2025 Year 08 Month 01 Day
Date of IRB - 2025 Year 08 Month 01 Day
Anticipated trial start date - 2025 Year 08 Month 01 Day
Last follow-up date - 2031 Year 07 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000068264
Disclaimer: Curated by HT Syndication.
